WEBINAR in collaboration with IPTA
Keynote speaker: Stuart C. Sweet, Medical Director, Paediatric Lung Transplant Program, Washington University School of Medicine in St. Louis, U.S.
Chairs: Maria Irene Bellini, Renal Transplant Surgeon, Belfast City Hospital, UK
Stephen Marks, Reader and Consultant in Paediatric Nephrology at University College London Great Ormond Street Institute of Child Health, UK
• Indication for paediatric lung transplantation: screening and listing of transplant candidates
• Management of the waiting list candidate
• Immunosuppression in paediatric lung transplantation
• Early management: preventing, recognising and managing complications
• Long-term management and complications: case presentations
Paediatric lung transplantation is a viable option for infants, children and adolescents with end stage pulmonary parenchymal and pulmonary vascular diseases. Although complications and outcomes are similar to that of adult lung transplantation, paediatric lung transplant is unique because the spectrum of diagnoses includes congenital lung diseases and a higher percentage of cystic fibrosis, growth and development must be considered, the challenges of adolescence impact outcomes, and the developing immune system in children affects the response to the graft and the risks posed by viral infections. In this webinar, we discuss indications for paediatric lung transplantation, listing and management strategies, recognition and management of key early and late complications and emphasize areas where paediatric lung transplantation is unique.
The recording is available on demand via https://www.esottransplantlive.org/